ARCH Venture Fund VIII Overage, L.P., 10% Owner at Codiak BioSciences, Inc. (CDAK), bought 5,000,000 shares at $1.50 ($7.5M) on 2022-09-13, disclosed to the SEC on 2022-09-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.